id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-E-2042-0007,FDA,FDA-2020-E-2042,Letter to U S Patent and Trademark Office,Other,Letter(s),2022-08-01T04:00:00Z,2022,8,2022-08-01T04:00:00Z,,2022-08-01T13:23:32Z,,0,0,0900006485200271
FDA-2020-E-2042-0006,FDA,FDA-2020-E-2042,"Determination of Regulatory Review
Period for Purposes of Patent
Extension; AKLIEF",Notice,Determinations,2021-11-04T04:00:00Z,2021,11,2021-11-04T04:00:00Z,2022-01-04T04:59:59Z,2021-11-04T16:03:55Z,2021-24077,0,0,0900006484e1b478
FDA-2020-E-2042-0005,FDA,FDA-2020-E-2042,Letter to U S Patent and Trademark Office,Other,Letter(s),2021-10-22T04:00:00Z,2021,10,2021-10-22T04:00:00Z,,2021-10-26T14:37:19Z,,0,0,0900006484de516a
FDA-2020-E-2042-0004,FDA,FDA-2020-E-2042,Patent Term Extension Letter from Office of Patent Legal Administration to FDA CDER,Other,Letter(s),2021-07-26T04:00:00Z,2021,7,2021-07-26T04:00:00Z,,2021-07-26T18:05:54Z,,0,0,0900006484c0fcb0
FDA-2020-E-2042-0003,FDA,FDA-2020-E-2042,Letter to U S Patent and Trademark Office,Other,Letter(s),2020-12-14T05:00:00Z,2020,12,2020-12-14T05:00:00Z,,2020-12-14T15:42:53Z,,0,0,090000648499ca49
FDA-2020-E-2042-0001,FDA,FDA-2020-E-2042,Letter from U S Patent and Trademark Office to FDA CDER,Other,Letter(s),2020-10-02T04:00:00Z,2020,10,2020-10-02T04:00:00Z,,2020-10-02T19:11:40Z,,0,0,09000064848b7f2d
FDA-2020-E-2042-0002,FDA,FDA-2020-E-2042,Patent Term Extension Application for AKLIEF,Other,Application,2020-10-02T04:00:00Z,2020,10,2020-10-02T04:00:00Z,,2020-10-02T19:12:30Z,,0,0,09000064848b7f31